Literature DB >> 32234931

Clinical Significance of Dynamic Neutrophil-lymphocyte Ratio Changes in Patients With Colorectal Cancer.

Naoki Ashizawa1, Shinji Furuya2, Shoda Katsutoshi1, Makoto Sudo1, Hidenori Akaike1, Naohiro Hosomura1, Yoshihiko Kawaguchi1, Hidetake Amemiya1, Hiromichi Kawaida1, Shingo Inoue1, Hiroshi Kono1, Daisuke Ichikawa1.   

Abstract

BACKGROUND/AIM: Elevated neutrophil-lymphocyte ratio (NLR) has been reported to be a poor prognostic factor in patients with colorectal cancer (CRC). However, no studies have focused on the dynamic change of preoperative NLR (pre-NLR) in CRC patients. We investigated the prognostic value of the change in NLR (ΔNLR) in CRC patients before and after surgery. PATIENTS AND METHODS: We retrospectively analyzed the data from 307 patients with stage II or III CRC. We compared the clinicopathological factors, OS, and DFS among the various NLR factors.
RESULTS: The 5-year OS rate of the high ΔNLR group was significantly lower than that of the low ΔNLR group (p<0.01). The 5-year DFS rates of the high ΔNLR groups were worse than those in the low ΔNLR groups. In the multivariate analysis, ΔNLR was an independent prognostic factor (p=0.011).
CONCLUSION: Decreasing post-NLR was related to better OS and DFS even in high pre-NLR patients with CRC. Copyright
© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Colorectal cancer; dynamic change of NLR; neutrophils-lymphocyte ratio; perioperative nutrition management; prognosis

Mesh:

Year:  2020        PMID: 32234931     DOI: 10.21873/anticanres.14197

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Longitudinal changes in personalized platelet count metrics are good indicators of initial 3-year outcome in colorectal cancer.

Authors:  Zoltan Herold; Magdolna Herold; Julia Lohinszky; Attila Marcell Szasz; Magdolna Dank; Aniko Somogyi
Journal:  World J Clin Cases       Date:  2022-07-16       Impact factor: 1.534

2.  Improvement in the Neutrophil-Lymphocyte Ratio after Combined Fluorouracil, Leucovorina and Oxaliplatino based (FOLFOX) Chemotherapy for Stage III Colon Cancer is Associated with Improved Minimal Residual Disease and Outcome.

Authors:  Nigel P Murray; Ricardo Villalon; Dan Hartmann; Patricia Maria Rodriguez; Socrates Aedo
Journal:  Asian Pac J Cancer Prev       Date:  2022-02-01

3.  Models Based on Dynamic Clinicopathological Indices for Predicting Prognosis During the Perioperative Period for Patients with Colorectal Cancer.

Authors:  Yifei Ma; Ping Lu; Xinjun Liang; Shaozhong Wei
Journal:  J Inflamm Res       Date:  2021-04-21

4.  Association between early change in neutrophil-to-lymphocyte ratio after radical cystectomy and treatment outcomes.

Authors:  Haim Herzberg; Karin Lifshitz; Shay Golan; Jack Baniel; Kamil Malshy; Azik Hoffman; Gilad E Amiel; Rani Zreik; Yuval Freifeld; Yoram Dekel; Rinat Lasmanovich; Alon Lazarovich; Barak Rosenzweig; Zohar Dotan; Ofer Yossepowitch; Roy Mano
Journal:  BJU Int       Date:  2022-05-17       Impact factor: 5.969

5.  Plasma soluble human leukocyte antigen G predicts the long-term prognosis in patients with colorectal cancer.

Authors:  Feiyan Jiao; Jianping Zhou; Haiyan Sun; Xiaolong Song; Yu Song
Journal:  Transl Cancer Res       Date:  2020-06       Impact factor: 1.241

6.  Baseline neutrophil-lymphocyte ratio can be associated with hematoma expansion in patients with intracerebral hemorrhage: a retrospective observational study.

Authors:  Ehsan Alimohammadi; Seyed Reza Bagheri; Parand Mardanpour; Farid Moradi; Fatemeh Arjmandnia; Narges Esmaeili
Journal:  BMC Neurosci       Date:  2022-03-25       Impact factor: 3.288

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.